Phase III randomized clinical studies to evaluate the immunogenicity, lot-to-lot consistency, and safety of ROTAVAC ® liquid formulations (ROTAVAC 5C & 5D) and non-inferiority comparisons with licensed ROTAVAC ® (frozen formulation) in healthy infants

Volume 19, Issue 3, December 2023 .

Source: Human Vaccines and Immunotherapeutics - November 16, 2023 Category: Allergy & Immunology Authors: Krishna Kumari PSiddharth Reddy ChitetiVinay K. AileniSudhir BabjiWilliam C. BlackwelderAshok KumarJayant VaghaUma NayakMonjori MitraNarayanaappa DSonali KarSangeeta YadavSwamy NaiduNiranjan MahantshettiVasant KhalatkarSatyajit MohapatraP. K. PurthiPawan Source Type: research